Beigene Ltd (NASDAQ:BGNE)
| 222.97 Delayed Data As of Jun 01 |  +2.04 / +0.92%Today’s Change | 124.46 Today|||52-Week Range 280.62 | +1.38% Year-to-Date |
Latest BGNE News | Press Releases
No recent news for Beigene Ltd.
Today’s Trading
| Previous close | 220.93 |
| Today’s open | 220.71 |
| Day’s range | 220.71 - 226.99 |
| Volume | 6,454 |
| Average volume (3 months) | 206,243 |
| Market cap | $24.8B |
Data as of 3:59pm ET, 06/01/2023
Growth & Valuation
| Earnings growth (last year) | -27.55% |
| Earnings growth (this year) | +35.80% |
| Earnings growth (next 5 years) | -18.89% |
| Revenue growth (last year) | +20.37% |
| P/E ratio | NM |
| Price/Sales | 16.02 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TEVATeva Pharmaceutical | -0.01 | -0.14% |
| BBIOBridgeBio Pharma Inc | +0.27 | +1.97% |
| IDRSFIdorsia Ltd | +0.15 | +1.76% |
| ---- |
Data as of 3:59pm ET, 06/01/2023
Financials
| Next reporting date | August 25, 2023 |
| EPS forecast (this quarter) | -$3.45 |
| Annual revenue (last year) | $1.4B |
| Annual profit (last year) | -$2.0B |
| Net profit margin | -141.52% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters George Town, George Town |
Forecasts
